| Year |
Citation |
Score |
| 2023 |
Oda JM, den Hartigh AB, Jackson SM, Tronco AR, Fink SL. The unfolded protein response components IRE1α and XBP1 promote human coronavirus infection. Mbio. e0054023. PMID 37306512 DOI: 10.1128/mbio.00540-23 |
0.329 |
|
| 2022 |
Ravindran V, Wagoner J, Athanasiadis P, Den Hartigh AB, Sidorova JM, Ianevski A, Fink SL, Frigessi A, White J, Polyak SJ, Aittokallio T. Discovery of host-directed modulators of virus infection by probing the SARS-CoV-2-host protein-protein interaction network. Briefings in Bioinformatics. PMID 36305426 DOI: 10.1093/bib/bbac456 |
0.354 |
|
| 2013 |
Xavier MN, Winter MG, Spees AM, den Hartigh AB, Nguyen K, Roux CM, Silva TM, Atluri VL, Kerrinnes T, Keestra AM, Monack DM, Luciw PA, Eigenheer RA, Bäumler AJ, Santos RL, et al. PPARγ-mediated increase in glucose availability sustains chronic Brucella abortus infection in alternatively activated macrophages. Cell Host & Microbe. 14: 159-70. PMID 23954155 DOI: 10.1016/J.Chom.2013.07.009 |
0.705 |
|
| 2013 |
de Jong MF, Starr T, Winter MG, den Hartigh AB, Child R, Knodler LA, van Dijl JM, Celli J, Tsolis RM. Sensing of bacterial type IV secretion via the unfolded protein response. Mbio. 4: e00418-12. PMID 23422410 DOI: 10.1128/Mbio.00418-12 |
0.62 |
|
| 2012 |
Sun YH, de Jong MF, den Hartigh AB, Roux CM, Rolán HG, Tsolis RM. The small protein CydX is required for function of cytochrome bd oxidase in Brucella abortus. Frontiers in Cellular and Infection Microbiology. 2: 47. PMID 22919638 DOI: 10.3389/Fcimb.2012.00047 |
0.57 |
|
| 2011 |
Atluri VL, Xavier MN, de Jong MF, den Hartigh AB, Tsolis RM. Interactions of the human pathogenic Brucella species with their hosts. Annual Review of Microbiology. 65: 523-41. PMID 21939378 DOI: 10.1146/Annurev-Micro-090110-102905 |
0.703 |
|
| 2011 |
Silva TM, Paixão TA, Costa EA, Xavier MN, Sá JC, Moustacas VS, den Hartigh AB, Carvalho Neta AV, Oliveira SC, Tsolis R, Santos RL. Putative ATP-binding cassette transporter is essential for Brucella ovis pathogenesis in mice. Infection and Immunity. 79: 1706-17. PMID 21300772 DOI: 10.1128/Iai.01109-10 |
0.611 |
|
| 2011 |
Paschos A, den Hartigh A, Smith MA, Atluri VL, Sivanesan D, Tsolis RM, Baron C. An in vivo high-throughput screening approach targeting the type IV secretion system component VirB8 identified inhibitors of Brucella abortus 2308 proliferation. Infection and Immunity. 79: 1033-43. PMID 21173315 DOI: 10.1128/Iai.00993-10 |
0.692 |
|
| 2009 |
Paixão TA, Roux CM, den Hartigh AB, Sankaran-Walters S, Dandekar S, Santos RL, Tsolis RM. Establishment of systemic Brucella melitensis infection through the digestive tract requires urease, the type IV secretion system, and lipopolysaccharide O antigen. Infection and Immunity. 77: 4197-208. PMID 19651862 DOI: 10.1128/Iai.00417-09 |
0.645 |
|
| 2008 |
de Jong MF, Sun YH, den Hartigh AB, van Dijl JM, Tsolis RM. Identification of VceA and VceC, two members of the VjbR regulon that are translocated into macrophages by the Brucella type IV secretion system. Molecular Microbiology. 70: 1378-96. PMID 19019140 DOI: 10.1111/J.1365-2958.2008.06487.X |
0.572 |
|
| 2008 |
den Hartigh AB, Rolán HG, de Jong MF, Tsolis RM. VirB3 to VirB6 and VirB8 to VirB11, but not VirB7, are essential for mediating persistence of Brucella in the reticuloendothelial system. Journal of Bacteriology. 190: 4427-36. PMID 18469100 DOI: 10.1128/Jb.00406-08 |
0.596 |
|
| 2008 |
Rolán HG, den Hartigh AB, Kahl-McDonagh M, Ficht T, Adams LG, Tsolis RM. VirB12 is a serological marker of Brucella infection in experimental and natural hosts. Clinical and Vaccine Immunology : Cvi. 15: 208-14. PMID 18077620 DOI: 10.1128/Cvi.00374-07 |
0.612 |
|
| 2006 |
Kahl-McDonagh MM, Elzer PH, Hagius SD, Walker JV, Perry QL, Seabury CM, den Hartigh AB, Tsolis RM, Adams LG, Davis DS, Ficht TA. Evaluation of novel Brucella melitensis unmarked deletion mutants for safety and efficacy in the goat model of brucellosis. Vaccine. 24: 5169-77. PMID 16697090 DOI: 10.1016/J.Vaccine.2006.04.005 |
0.555 |
|
| 2005 |
Sun YH, den Hartigh AB, Tsolis RM, Ficht TA. Laboratory maintenance of Brucella abortus. Current Protocols in Microbiology. Unit 3B.1. PMID 18770565 DOI: 10.1002/9780471729259.Mc03B01S00 |
0.471 |
|
| 2005 |
Sun YH, Rolán HG, den Hartigh AB, Sondervan D, Tsolis RM. Brucella abortus virB12 is expressed during infection but is not an essential component of the type IV secretion system. Infection and Immunity. 73: 6048-54. PMID 16113325 DOI: 10.1128/Iai.73.9.6048-6054.2005 |
0.673 |
|
| 2004 |
den Hartigh AB, Sun YH, Sondervan D, Heuvelmans N, Reinders MO, Ficht TA, Tsolis RM. Differential requirements for VirB1 and VirB2 during Brucella abortus infection. Infection and Immunity. 72: 5143-9. PMID 15322008 DOI: 10.1128/Iai.72.9.5143-5149.2004 |
0.646 |
|
| 2002 |
Sun YH, den Hartigh AB, Santos RL, Adams LG, Tsolis RM. virB-Mediated survival of Brucella abortus in mice and macrophages is independent of a functional inducible nitric oxide synthase or NADPH oxidase in macrophages. Infection and Immunity. 70: 4826-32. PMID 12183526 DOI: 10.1128/Iai.70.9.4826-4832.2002 |
0.612 |
|
| Show low-probability matches. |